IGF-I, IGFBP-3 and breast cancer in young women: A pooled re-analysis of three prospective studies

European Journal of Cancer Prevention

Volumn 14, Issue 6, 2005, Pages 493-496

  Rinaldi, Sabina ^a   Toniolo, Paolo ^b   Muti, Paola ^c   Lundin, Eva ^d,e   Zeleniuch Jacquotte, Anne ^b   Arslan, Alan ^b   Micheli, Andrea ^c   Lenner, Per ^d   Dossus, Laure ^a   Krogh, Vittorio ^c   Shore, Roy E ^b   Koenig, Karen L ^b   Riboli, Elio ^a   Stattin, Pär ^d   Berrino, Franco ^c   Hallmans, Göran ^d   Lukanova, Annekatrin ^b   Kaaks, Rudolf ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^e UMEÅ UNIVERSITY   (Sweden)

Author keywords

Breast cancer; Cohort studies; Insulin like growth factor binding protein 3; Insulin like growth factor I

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MEASUREMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SWEDEN; UNITED STATES;

ADULT; AGE OF ONSET; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; ITALY; MIDDLE AGED; NEW YORK; PREMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS; SWEDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 28044443343     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200512000-00001     Document Type: Article

References (15)

1. Bohlke K, Cramer DW, Trichopoulos D, Mantzoros CS (1998). Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. Epidemiology 9: 570-573.
2. Bruning PF, Van Doorn J, Bonfrer JM, Van Noord PA, Korse CM, Linders TC, Hart AA (1995). Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int J Cancer 62: 266-270.
3. Chan JM, Stampfer MJ, Giovannucci E, et al. (1998). Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279: 563-566.
4. Del Giudice ME, Fantus IG, Ezzat S, McKeown-Eyssen G, Page D, Goodwin PJ (1998). Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47: 111-120.
5. Hankinson SE, Willett WC, Colditz GA, et al. (1998). Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351: 1393-1396.
6. Kaaks R, van der Tweel I, Van Noord PA, Riboli E (1994). Efficient use of biological banks for biochemical epidemiology: exploratory hypothesis testing by means of a sequential t-test. Epidemiology 5: 429-438.
7. Kaaks R, Rinaldi S, Lukanova A, Akhmedkhanov A, Zeleniuch-Jacquotte A, Toniolo P (2001). Correspondence re: Giovannucci et al., A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 9: 345-349, 2000. Cancer Epidemiol Biomarkers Prev 10: 1103-1104.
8. Kaaks R, Lundin E, Rinaldi S, et al. (2002). Prospective study of IGF-I, IGF-binding proteins, and breast cancer risk, in northern and southern Sweden. Cancer Causes Control 13: 307-316.
9. Krajcik RA, Borofsky ND, Massardo S, Orentreich N (2002). Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Cancer Epidemiol Biomarkers Prev 11: 1566-1573.
10. Ma J, Pollak MN, Giovannucci E, et al. (1999). Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91: 620-625.
11. Muti P, Quattrin T, Grant BJ, et al. (2002). Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 11: 1361-1368.
12. Peyrat JP, Bonneterre J, Hecquet B, et al. (1993). Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. Eur J Cancer 29A: 492-497.
13. Rinaldi S, Kaaks R, Zeleniuch-Jacquotte A, et al. (2005). Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays. Cancer Epidemiol Biomarkers Prev 14: 48-52.
14. Toniolo P, Bruning PF, Akhmedkhanov A, et al. (2000). Serum insulin-like growth factor-I and breast cancer. Int J Cancer 88: 828-832.
15. Yu H, Jin F, Shu XO, et al. (2002). Insulin-like growth factors and breast cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev 11: 705-712.